Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Jan 19;2011(1):CD004030.
doi: 10.1002/14651858.CD004030.pub3.

Enteral tube feeding for amyotrophic lateral sclerosis/motor neuron disease

Hans Dieter Katzberg  1 , Michael Benatar
Affiliations

Enteral tube feeding for amyotrophic lateral sclerosis/motor neuron disease

Hans Dieter Katzberg et al. Cochrane Database Syst Rev. .

Update in

Abstract

Background: Enteral feeding (tube feeding) is offered to many people with amyotrophic lateral sclerosis/motor neuron disease experiencing difficulty swallowing (dysphagia) and maintaining adequate nutritional intake leading to weight loss.

Objectives: To examine the efficacy of percutaneous endoscopic gastrostomy placement or other tube feeding placement on: (1) survival;(2) nutritional status; (3) quality of life;(4) minor and major complications of percutaneous endoscopic gastrostomy.

Search strategy: We searched the Cochrane Neuromuscular Disease Group Trials Register (24 November 2009), MEDLINE (from January 1966 to September 2009), and EMBASE (from January 1980 to September 2009) for all papers on enteral tube feeding in amyotrophic lateral sclerosis/motor neuron disease. The results were screened to identify randomised controlled trials and to identify non-randomized studies that might be worthy of review and discussion. We checked references in published articles and enlisted personal communications to identify any additional references.

Selection criteria: A priori selection criteria included randomised and quasi-randomized controlled trials evaluating the efficacy of percutaneous endoscopic gastrostomy or other feeding tube placement. Since no such trials were discovered, all prospective and retrospective controlled studies were reviewed in the 'Background' or 'Discussion' sections of the review.

Data collection and analysis: We independently assessed study design and extracted data. We considered the following outcomes: (1) survival rate in months (of primary interest), (2) nutritional status measured by weight change, change in body mass index, or other quantitative index of nutritional status, (3) self-perceived quality of life and (4) safety of the procedure as indicated by minor and major complications of surgical or radiological guided PEG tube insertion.

Main results: We found no randomised controlled trials comparing the efficacy of enteral tube feeding with those people who continued to eat orally, without enteral feeding. We summarized the results of retrospective and prospective studies in the 'Discussion' section.

Authors' conclusions: There are no randomised controlled trials to indicate whether enteral tube feeding is beneficial compared to continuation of oral feeding for any of the outcome measures. The 'best' evidence to date suggests a survival advantage for some people with amyotrophic lateral sclerosis/motor neuron disease, but these conclusions are tentative. Evidence for improved nutrition is also incomplete but tentatively favorable. Quality of life has been addressed in studies and needs more attention. Based on a number of recent non-randomized studies comparing surgical and radiographic approaches to feeding tube insertion these two procedures for PEG tube insertion appear to be equivalent.

PubMed Disclaimer

Conflict of interest statement

None

Update of

References

Additional references

Allison 2000
    1. Allison SP, Rawlings J, Field J, Bean N, Stephen AD. Nutrition in the elderly hospital patient ‐ Nottingham studies. Journal of Nutrition, Health & Aging 2000;4(1):54‐7. - PubMed
Bak 1994
    1. Bak S, Bak L. Symptomatic treatment of amyotrophic lateral sclerosis [Symptomatisk behandling af amyotrofisk lateralsklerose]. Ugeskr Laeger 1994;156(28):4138‐40. - PubMed
Beghi 2008
    1. Beghi E, Millul A, Logroscino G, Vitelli E, Micheli A. SLALOM Group. Outcome measures and prognostic indicators in patients with amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis 2008;9(3):163‐7. - PubMed
Boitano 2001
    1. Boitano LJ, Jordan T, Benditt JO. Noninvasive ventilation allows gastrostomy tube placement in patients with advanced ALS. Neurology 2001;56(3):413‐4. [MEDLINE: ] - PubMed
Bradley 2004
    1. Bradley WG, Anderson F, Gowda N, Miller RG, ALS CARE Study Group. Changes in the management of ALS since the publication of the AAN ALS Practice Parameter 1999. Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders 2004;5(4):240‐4. - PubMed
Brooks 1994
    1. Brooks BR. El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. Subcommittee on motor neuron diseases/amyotrophic lateral sclerosis of the World Federation of Neurology Research Group on Neuromuscular Diseases and the El Escorial 'Clinical limits of ALS' Workshop Contributors. Journal of the Neurological Sciences 1994 Suppl;124:96‐107. [MEDLINE: ] - PubMed
Brooks 2000
    1. Brooks BR, Miller RG, Swash M, Munsat TL, World Federation of Neurology Research Group on Motor Neuron Disease. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders 2000;1:293‐9. [MEDLINE: ] - PubMed
Chiò 1999
    1. Chiò A, Finocchiaro E, Meineri P, Bottacchi E, Schiffer D. Safety and factors related to survival after percutaneous endoscopic gastrostomy in ALS. ALS Percutaneous Endoscopic Gastrostomy Study Group. Neurology 1999;53(5):1123‐5. [MEDLINE: ] - PubMed
Chiò 2002
    1. Chiò A, Mora G, Leone M, Mazzini L, Cocito D, Giordana MT, et al. Early symptom progression rate is related to ALS outcome: a prospective population based study. Neurology 2002;59(1):99‐103. - PubMed
Chiò 2004
    1. Chiò A, Galletti R, Finocchiaro C, Righi D, Ruffino MA, Calvo A, et al. Percutaneous radiological gastrostomy: a safe and effective method of nutritional tube placement in advanced ALS. Journal of Neurology, Neurosurgery and Psychiatry 2004;75(4):645‐7. - PMC - PubMed
Chiò 2006
    1. Chiò A, Bottacchi E, Buffa C, Mutani R, Mora G, PARALS. Positive effects of tertiary centres for amyotrophic lateral sclerosis on outcome and use of hospital facilities. Journal of Neurology, Neurosurgery and Psychiatry 2006;77(8):948‐50. - PMC - PubMed
Czaplinski 2006
    1. Czaplinski A, Yen AA, Simpson EP, Appel SH. Slower disease progression and prolonged survival in contemporary patients with amyotrophic lateral sclerosis: is the natural history of amyotrophic lateral sclerosis changing?. Archives of Neurology 2006;63(8):1139‐43. - PubMed
Desport 2000
    1. Desport JC, Preux PM, Truong CT, Courat L, Vallat JM, Couratier P. Nutritional assessment and survival in ALS patients. Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders 2000;1(2):91‐6. [MEDLINE: ] - PubMed
Forbes 2004
    1. Forbes RB, Colville S, Swingler RJ, Scottish Motor Neurone Disease Research Group. Frequency, timing and outcome of gastrostomy tubes for amyotrophic lateral sclerosis/motor neurone disease ‐ a record linkage study from the Scottish Motor Neurone Disease Register. Journal of Neurology 2004;251(7):813‐7. - PubMed
Gregory 2002
    1. Gregory S, Siderowf A, Golaszewski AL, McCluskey L. Gastrostomy insertion in ALS patients with low vital capacity: respiratory support and survival. Neurology 2002;58(3):485‐7. [MEDLINE: ] - PubMed
Higgins 2008
    1. Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.2 [updated September 2009]. The Cochrane Collaboration, 2009. Available from www.cochrane‐handbook.org.
Jokelainen 1977
    1. Jokelainen M. Amyotrophic lateral sclerosis in Finland II: Clinical characteristics. Acta Neurologica Scandinavica 1977;56(3):191‐204. - PubMed
Karitzky 2001
    1. Karitzky J, Ludolph AC. Imaging and neurochemical markers for diagnosis and disease progression in ALS. Journal of the Neurological Sciences 2001;191(1‐2):35‐41. [MEDLINE: ] - PubMed
Kasarskis 1999
    1. Kasarskis EJ, Scarlata D, Hill R, Fuller C, Stambler N, Cedarbaum JM. A retrospective study of percutaneous endoscopic gastrostomy in ALS patients during the BDNF and CNTF trials. Journal of the Neurological Sciences 1999;169(1‐2):118‐25. [MEDLINE: ] - PubMed
Klor 1999
    1. Klor BM, Milianti FJ. Rehabilitation of neurogenic dysphagia with percutaneous endoscopic gastrostomy. Dysphagia 1999;14(3):162‐4. [MEDLINE: ] - PubMed
Lechtzin 2001
    1. Lechtzin N, Wiener CM, Clawson L, Chaudhry V, Diette GB. Hospitalization in amyotrophic lateral sclerosis: causes, costs and outcomes. Neurology 2001;56(6):753‐7. - PubMed
Mazzini 1995
    1. Mazzini L, Corra T, Zaccala M, Mora G, Piano M, Galante M. Percutaneous endoscopic gastrostomy and enteral nutrition in amyotrophic lateral sclerosis. Journal of Neurology 1995;242(10):695‐8. [MEDLINE: ] - PubMed
Miller 1999
    1. Miller RG, Rosenberg JA, Gelinas DF, Mitsumoto H, Newman D, Sufit R, et al. Practice parameter: the care of the patient with amyotrophic lateral sclerosis (an evidence‐based review): report of the Quality Standards Subcommittee of the American Academy of Neurology: ALS Practice Parameters Task Force. Neurology 1999;52(7):1311‐23. [MEDLINE: ] - PubMed
Miller 2009
    1. Miller RG, Jackson CE, Kasarskis EJ, England JD, Forshew D, Johnston W, et al. Practice Parameter update: The care of the patient with amyotrophic lateral sclerosis: drug, nutritional, and respiratory therapies (an evidence‐based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2009;73(15):1218‐26. - PMC - PubMed
Mitchell 2006
    1. Mitchell JD, O'Brien MR, Joshi M. Audit of outcomes in motor neuron disease (MND) patients treated with riluzole. Amyotrophic Lateral Sclerosis 2006;7(2):67‐71. - PubMed
Mitsumoto 2003
    1. Mitsumoto H, Davidson M, Moore D, Gad N, Brandis M, Ringel S, et al. Percutaneous endoscopic gastrostomy (PEG) in patients with ALS and bulbar dysfunction. Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders 2003;4(3):177‐85. - PubMed
Murphy 2008
    1. Murphy M, Quinn S, Young J, Parkin P, Taylor B. Increasing incidence of ALS in Canterbury, New Zealand: a 22‐year study. Neurology 2008;71(23):1889‐95. - PubMed
Neudert 2001
    1. Neudert C, Oliver D, Wasner M, Borasio GD. The course of the terminal phase in patients with amyotrophic lateral sclerosis. Journal of Neurology 2001;248(7):612‐6. - PubMed
Parmar 1998
    1. Parmar MK, Torri V, Stewart L. Extracting summary statistics to perform meta‐analyses of the published literature for survival endpoints. Statistics in Medicine 1998;17(24):2815‐34. [MEDLINE: ] - PubMed
Seki 2000
    1. Seki H, Kameya T, Kimura I. A survey of current nutrition therapy for the ALS patients in Japanese national sanatoriums. Rinsho Shinkeigaku ‐ Clinical Neurology 2000;40(11):1083‐9. - PubMed
Shaw 2004
    1. Shaw AS, Ampong MA, Rio A, McClure J, Leigh PN, Sidhu PS. Entristar skin‐level gastrostomy tube: primary placement with radiologic guidance in patients with amyotrophic lateral sclerosis. Radiology 2004;233(2):392‐9. - PubMed
Silani 1998
    1. Silani V, Kasarskis EJ, Yanagisawa N. Nutritional management in amyotrophic lateral sclerosis: a worldwide perspective. Journal of Neurology 1998;245(Suppl 2):S13‐9. - PubMed
Sorenson 2007
    1. Sorenson EJ, Crum B, Stevens JC. Incidence of aspiration pneumonia in ALS in Olmsted County, MN. Amyotrophic Lateral Sclerosis 2007;8(2):87‐9. - PubMed
Strong 1999
    1. Strong MJ, Rowe A, Rankin RN. Percutaneous gastrojejunostomy in amyotrophic lateral sclerosis. Journal of the Neurological Sciences 1999;169(1‐2):128‐32. - PubMed
Thornton 2002
    1. Thornton FJ, Fotheringham T, Alexander M, Hardiman O, McGrath FP, Lee MJ. Amyotrophic lateral sclerosis: enteral nutrition provision ‐ endoscopic or radiologic gastrostomy?. Radiology 2002;224(3):713‐7. - PubMed
Yanagisawa 1996
    1. Yanagisawa N, Shindo M. Nationwide study on the natural course of amyotrophic lateral sclerosis in Japan. Annual report of the Research Committee of CNS Degenerative Diseases, Ministry of Health and Welfare in Japan for the year 1995. Matsumoto 1996:253‐5.

Publication types

LinkOut - more resources